Superworth

GLAUKOS price to book ratio GKOS

Market value divided by the book value of the company's net assets, since 2015.

Today, Nov 2, 2026
20.6×
10-year median
8.1×
Against its 10-year history
100th
percentile: 0 is its lowest day, 100 its highest
10-year range
1.7× to 20.6×
Peer median
5.0×

GLAUKOS' price to book ratio is 20.6× as of Nov 2, 2026.

That is above its ten-year median of 8.1×, higher than on 100% of days in the last ten years.

Over that time it ranged from 1.7× in Mar 2020 to 20.6× in Nov 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 5.0×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far20.6×8.2×20.6×
20258.7×5.6×13.2×
202412.5×8.1×13.6×
20238.1×3.9×8.4×
20223.8×3.1×5.1×
20213.5×3.1×6.8×
20205.1×1.7×13.1×
201910.7×10.7×16.7×
201812.3×6.9×16.2×
20176.7×6.6×15.0×
201610.4×5.2×12.3×
20158.4×6.6×11.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest GLAUKOS' size, closest first, today.

CompanyPrice to book ratio
GKOSGLAUKOS20.6×
SOLVSolventum3.0×
PENPenumbra8.3×
COOCooper Companies1.4×
ALGNAlign Technology2.6×
GMEDGlobus Medical2.2×
PODDInsulet7.5×
MSAMSA Safety5.1×
WSTWest Pharmaceutical Services9.7×
RMDResMed4.9×
HAEHaemonetics6.5×
Peer median5.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on GLAUKOS

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.